✦ LIBER ✦

Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer: cross-resistance to capecitabine

✍ Scribed by Yoshinori Ito; Yohei Osaki; Nahomi Tokudome; Tsutomu Sugihara; Shunji Takahashi; Takuji Iwase; Kiyohiko Hatake

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive factors for efficacy of capec

✍ Tomo Osako; Yoshinori Ito; Masaru Ushijima; Shunji Takahashi; Nahomi Tokudome; T 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 303 KB

Efficacy and safety of low-dose metronom

✍ P. Fedele; A. Marino; L. Orlando; P. Schiavone; A. Nacci; F. Sponziello; P. Rizz 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Efficacy and safety of trastuzumab plus

✍ Tomo Osako; Yoshinori Ito; Shunji Takahashi; Nahomi Tokudome; Takuji Iwase; Kiyo 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 293 KB

18 SAFETY AND EFFICACY OF LOW DOSE METRO

✍ P. Fedele; L. Orlando; P. Schiavone; P. Rizzo; N. Calvani; A. Marino; M. D'Amico 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Trastuzumab plus capecitabine vs. lapati

✍ Bian, Li; Wang, Tao; Zhang, Shaohua; Jiang, Zefei 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 150 KB

Capecitabine monotherapy in patients wit

✍ S.-H. Lee; J. Lee; J. Park; S. H. Park; K.-E. Lee; S. I. Lee; E. Nam; J. O. Park 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 106 KB